Business September 2, 2020 user HKAPI Policy Address Recommendation 2020 The Hong Kong Association of the Pharmaceutical Industry (HKAPI) submits this opinion paper, on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals, and providing 70% of treatment drugs in Hong Kong.Please download the full position paper here: http://bit.ly/HKAPI_PolicyAddress2020 Previous Post The Formation of New Board (2020 – 2022) Next Post Senior Executive Director takes top honour at APEC 2020 Lighthouse Award